Published in Ann N Y Acad Sci on October 20, 1999
Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol (2012) 2.99
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol (2006) 1.72
Cutaneous hypothalamic-pituitary-adrenal axis homolog: regulation by ultraviolet radiation. Am J Physiol Endocrinol Metab (2011) 1.58
Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet (2001) 1.39
UVB Activates Hypothalamic-Pituitary-Adrenal Axis in C57BL/6 Mice. J Invest Dermatol (2014) 1.20
Skin as an endocrine organ: implications for its function. Drug Discov Today Dis Mech (2008) 1.19
Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol Endocrinol (2006) 1.16
Successful treatment of laser induced hypopigmentation with narrowband ultraviolet B targeted phototherapy. J Cutan Aesthet Surg (2013) 1.08
On the role of skin in the regulation of local and systemic steroidogenic activities. Steroids (2015) 1.01
Genetic variation of the cutaneous HPA axis: an analysis of UVB-induced differential responses. Gene (2013) 0.98
Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma. Expert Rev Dermatol (2007) 0.98
Pigment-independent cAMP-mediated epidermal thickening protects against cutaneous UV injury by keratinocyte proliferation. Exp Dermatol (2012) 0.82
Neuroendocrinology of the skin: An overview and selective analysis. Dermatoendocrinol (2011) 0.81
Norartocarpetin from a folk medicine Artocarpus communis plays a melanogenesis inhibitor without cytotoxicity in B16F10 cell and skin irritation in mice. BMC Complement Altern Med (2013) 0.79
Pharmacologic induction of epidermal melanin and protection against sunburn in a humanized mouse model. J Vis Exp (2013) 0.76
Phototherapy in Scleroderma. Dermatol Ther (Heidelb) (2016) 0.75
Bioactive forms of vitamin D selectively stimulate the skin analog of the hypothalamus-pituitary-adrenal axis in human epidermal keratinocytes. Mol Cell Endocrinol (2016) 0.75
Increased therapeutic efficacy of a newly synthesized tyrosinase inhibitor by solid lipid nanoparticles in the topical treatment of hyperpigmentation. Drug Des Devel Ther (2016) 0.75
Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol (1999) 3.97
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Multiple primary melanomas: data and significance. Plast Reconstr Surg (1995) 1.46
Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Lab Invest (2000) 1.42
Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta (1996) 1.39
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet (1989) 1.33
5,6-Dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature (1978) 1.31
Involvement of an SHP-2-Rho small G protein pathway in hepatocyte growth factor/scatter factor-induced cell scattering. Mol Biol Cell (2000) 1.31
Polymerization of 5,6-dihydroxyindole-2-carboxylic acid to melanin by the pmel 17/silver locus protein. Eur J Biochem (1996) 1.31
Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene (1992) 1.28
Factors regulating growth and pigmentation of melanoma cells. J Invest Dermatol (1976) 1.23
bcl-2 expression in epidermal keratinocytic diseases. Cancer (1994) 1.23
Melanoma x macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis (1998) 1.23
Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma. Cancer (1999) 1.22
Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration. J Invest Dermatol (2000) 1.15
Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma. Oncogene (2008) 1.13
A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids. Cancer Res (2000) 1.11
Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell Dev Biol Anim (2001) 1.07
What are subcutaneous adipocytes really good for? Exp Dermatol (2007) 1.06
Mast cell involvement in murine hair growth. Dev Biol (1994) 1.06
High-molecular-weight forms of tyrosinase and the tyrosinase-related proteins: evidence for a melanogenic complex. J Invest Dermatol (1994) 1.06
Possible involvement of proteolytic degradation of tyrosinase in the regulatory effect of fatty acids on melanogenesis. J Lipid Res (1999) 1.05
Involvement of EGF receptor activation in the induction of cyclooxygenase-2 in HaCaT keratinocytes after UVB. Exp Dermatol (2003) 1.05
New regulators of melanogenesis are associated with purified tyrosinase isozymes. J Invest Dermatol (1982) 1.05
What's the use of generating melanin? Exp Dermatol (1999) 1.04
Demonstration of tyrosinase in the adult bovine uveal tract and retinal pigment epithelium. Invest Ophthalmol Vis Sci (1978) 1.03
A new human photosensitive subject with a defect in the recovery of DNA synthesis after ultraviolet-light irradiation. J Invest Dermatol (1981) 1.03
Effects of various drugs on bladder function in conscious rats. Jpn J Pharmacol (1989) 1.03
Partial improvement of Olmsted syndrome with etretinate. Pediatr Dermatol (1993) 1.03
Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells. J Invest Dermatol (2000) 1.03
The biosynthesis of mammalian melanin. Am Sci (1982) 1.03
On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders. Br J Dermatol (2009) 1.02
Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors. Cancer (1999) 1.02
Roles for the protein tyrosine phosphatase SHP-2 in cytoskeletal organization, cell adhesion and cell migration revealed by overexpression of a dominant negative mutant. Oncogene (2000) 1.02
Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int J Oncol (2006) 1.02
Expression of protooncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines. Dig Dis Sci (1998) 1.02
Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J Pineal Res (2006) 1.01
Depigmenting effect of alpha-tocopheryl ferulate on normal human melanocytes. Pigment Cell Res (2000) 1.01
Amelanotic acral lentiginous malignant melanoma. Br J Dermatol (1999) 1.00
Modification of melanogenesis in cultured human melanoma cells. In Vitro Cell Dev Biol Anim (2000) 1.00
Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with food-dependent exercise-induced anaphylaxis. Br J Dermatol (2001) 0.99
New regulatory factors for melanogenesis: developmental changes in neonatal mice of various genotypes. Dev Biol (1983) 0.99
Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J (1998) 0.99
Inhibition of the motility and growth of B16F10 mouse melanoma cells by dominant negative mutants of Dok-1. Mol Cell Biol (2001) 0.99
Steroidogenesis in the human skin: 21-hydroxylation in cultured keratinocytes. J Steroid Biochem Mol Biol (2001) 0.99
Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs. Anticancer Res (2001) 0.98
Evidence that dopachrome tautomerase is a ferrous iron-binding glycoprotein. FEBS Lett (1992) 0.97
Linoleic acid and alpha-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin. Arch Dermatol Res (1998) 0.97
Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97
Effects of thyroxine and low oxygen tension on chondrogenic expression in cell culture. Dev Biol (1969) 0.97
Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett (1998) 0.97
Increase in melanin formation and promotion of cytotoxicity in cultured melanoma cells caused by phosphorylated isomers of L-dopa. Cancer Res (1986) 0.96
Skin histoculture assay for studying the hair cycle. In Vitro Cell Dev Biol (1993) 0.95
Mechanisms of inhibitory effects of CoQ10 on UVB-induced wrinkle formation in vitro and in vivo. Biofactors (2008) 0.94
Expression of tyrosinase, TRP-1 and TRP-2 in ultraviolet-irradiated human melanomas and melanocytes: TRP-2 protects melanoma cells from ultraviolet B induced apoptosis. Melanoma Res (1999) 0.94
Effect of stress on atopic dermatitis: investigation in patients after the great hanshin earthquake. J Allergy Clin Immunol (1999) 0.94
Spatiotemporal expression, distribution, and processing of POMC and POMC-derived peptides in murine skin. J Histochem Cytochem (2000) 0.93
Human monocyte x mouse melanoma fusion hybrids express human gene. Gene (2001) 0.93
Fusion hybrids with macrophage and melanoma cells up-regulate N-acetylglucosaminyltransferase V, beta1-6 branching, and metastasis. Cell Growth Differ (2001) 0.93
Evidence for UV-associated activation of telomerase in human skin. Cancer Res (1997) 0.93
Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin. J Invest Dermatol (1997) 0.93
Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes. J Pineal Res (2007) 0.92
Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal human melanocytes. J Investig Dermatol Symp Proc (1999) 0.92
Fibroblast growth factors in normal and malignant melanocytes. Ann N Y Acad Sci (1991) 0.91
Correlation between the number of melanosomes, tyrosinase mRNA levels, and tyrosinase activity in cultured murine melanoma cells in response to various melanogenesis regulatory agents. J Cell Physiol (1995) 0.91
The fate of hair follicle melanocytes during the hair growth cycle. J Investig Dermatol Symp Proc (1999) 0.91
Epidermal changes caused by chronic low-dose UV irradiation induce wrinkle formation in hairless mouse. J Dermatol Sci (2001) 0.90
Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration. Cancer Gene Ther (2000) 0.90
c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi. Melanoma Res (1996) 0.90
Identification and characterization of two isozymic forms of arylamine N-acetyltransferase in Syrian hamster skin. J Invest Dermatol (1993) 0.90
Malignant schwannoma associated with xeroderma pigmentosum in a patient belonging to complementation group D. J Am Acad Dermatol (1991) 0.90
Accelerated disappearance of melanocytes in bcl-2-deficient mice. Cancer Res (1996) 0.90
Quantitative evaluation of skin condition in an epidemiological survey of females living in northern versus southern Japan. J Dermatol Sci (2001) 0.89
Biology of hypopigmentation. J Am Acad Dermatol (1988) 0.89
Melanin monomers within coated vesicles and premelanosomes in melanin synthesizing cells. J Invest Dermatol (1988) 0.89
Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor. Australas Phys Eng Sci Med (2003) 0.89
Ultraviolet B and melanocyte-stimulating hormone (MSH) stimulate mRNA production for alpha MSH receptors and proopiomelanocortin-derived peptides in mouse melanoma cells and transformed keratinocytes. J Invest Dermatol (1995) 0.89
A mild form of xeroderma pigmentosum assigned to complementation group G and its repair heterogeneity. J Invest Dermatol (1985) 0.88
Influence of chronic UV exposure and lifestyle on facial skin photo-aging--results from a pilot study. J Epidemiol (1999) 0.88
Cutaneous immunomodulation and coordination of skin stress responses by alpha-melanocyte-stimulating hormone. Ann N Y Acad Sci (1998) 0.88
Enzyme therapy of xeroderma pigmentosum: safety and efficacy testing of T4N5 liposome lotion containing a prokaryotic DNA repair enzyme. Photodermatol Photoimmunol Photomed (1996) 0.88
Enhanced expression of melanocortin-1 receptor (MC1-R) in normal human keratinocytes during differentiation: evidence for increased expression of POMC peptides near suprabasal layer of epidermis. J Invest Dermatol (1999) 0.88
Heterozygous HPS1 mutations in a case of Hermansky-Pudlak syndrome with giant melanosomes. Br J Dermatol (2000) 0.88
Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin. Radiat Res (1994) 0.87
UV-induced tyrosine phosphorylation of PKC delta and promotion of apoptosis in the HaCaT cell line. Biochem Biophys Res Commun (2001) 0.87
Choriocarcinoma presenting as a cutaneous metastasis. J Cutan Pathol (1995) 0.87